Healthcare -
Medical - Healthcare Information Services - NYSE - US
$ 26.21
2.14 %
$ 1.56 B
Market Cap
-35.42
P/E
1. INTRINSIC VALUE
Balance Sheet
Phreesia, Inc.
| Current Assets | 203 M |
| Cash & Short-Term Investments | 84.2 M |
| Receivables | 103 M |
| Other Current Assets | 16.3 M |
| Non-Current Assets | 185 M |
| Long-Term Investments | 0 |
| PP&E | 25.1 M |
| Other Non-Current Assets | 160 M |
| Current Liabilities | 114 M |
| Accounts Payable | 5.62 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 108 M |
| Non-Current Liabilities | 9.58 M |
| Long-Term Debt | 719 K |
| Other Non-Current Liabilities | 8.86 M |
EFFICIENCY
Earnings Waterfall
Phreesia, Inc.
| Revenue | 420 M |
| Cost Of Revenue | 135 M |
| Gross Profit | 285 M |
| Operating Expenses | 343 M |
| Operating Income | -55 M |
| Other Expenses | 3.54 M |
| Net Income | -58.5 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Phreesia, Inc.
| Net Income | -58.5 M |
| Depreciation & Amortization | 27.9 M |
| Capital Expenditures | -24.1 M |
| Stock-Based Compensation | 67 M |
| Change in Working Capital | -6.49 M |
| Others | 7.88 M |
| Free Cash Flow | 8.29 M |
Wall Street Analysts Price Targets
Phreesia, Inc.
Wall Street analysts predict an average 1-year price target for PHR of $31.4 , with forecasts ranging from
a
low of
$30 to a high of $34 .
PHR Lowest Price Target
Wall Street Target
30 USD
14.46%
PHR Average Price Target
Wall Street Target
31.4 USD
19.80%
PHR Highest Price Target
Wall Street Target
34 USD
29.72%
4. DIVIDEND
ANALYSIS
PHR does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Phreesia, Inc.
Sold
0-3 MONTHS
1.82 M USD 8
3-6 MONTHS
7.47 M USD 7
6-9 MONTHS
3.13 M USD 8
9-12 MONTHS
1.24 M USD 9
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Becker's Names Phreesia's Kristin Roberts as one of 2025's 100 Women in Health IT to Know
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Kristin Roberts has been named in Becker's Hospital Review's 2025 list of the 100 Women in Health IT to Know.
businesswire.com
- 2 weeks ago
Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
- 1 month ago
Phreesia: Monetization Playbook To Help Drive Revenue Acceleration
Phreesia delivered a solid 1Q26 with strong profitability and steady client growth, despite a slight deceleration in revenue growth versus last year. Monetization per client is improving, supported by successful product launches and a strategic focus on larger, higher-value customers. The new 2.5 million share buyback program signals management's confidence in the business and provides additional support for the stock.
seekingalpha.com
- 1 month ago
Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR ) Q1 2026 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Balaji Gandhi - CFO Chaim Indig - CEO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi William Jellison - D.A. Davidson Ryan MacDonald - Needham & Company Jeff Garro - Stephens Scott Schoenhaus - Keybank Jared Hass - William Blair Aaron Kempson - Citizens JMP Gene Mannheimer - Freedom Capital Markets Joe Vruwink - Baird Operator Good morning, ladies and gentlemen.
seekingalpha.com
- 1 month ago
Here's What Key Metrics Tell Us About Phreesia (PHR) Q1 Earnings
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
- 1 month ago
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.35 per share a year ago.
zacks.com
- 1 month ago
Phreesia Announces First Quarter Fiscal 2026 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values,” said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations w.
businesswire.com
- 1 month ago
Gear Up for Phreesia (PHR) Q1 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.
zacks.com
- 1 month ago
Phreesia Sets Release Date for Fiscal First Quarter 2026 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025.
businesswire.com
- 2 months ago
Wall Street Analysts Think Phreesia (PHR) Could Surge 28.02%: Read This Before Placing a Bet
The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zacks.com
- 2 months ago
Phreesia Maintains Its Momentum
Phreesia remains resilient, maintaining guidance and showing strong financial performance, with Q4 revenue growth of 15% year-over-year and improved cash flow. Despite a slight deceleration in customer growth, Phreesia's revenue per healthcare services client increased, driven by network solutions, and the company expects 13.6% revenue growth in fiscal 2026. Future growth drivers include patient education initiatives and Post-Script Engagement, while competition is seen as beneficial, enhancing market awareness and adoption of healthcare solutions.
seekingalpha.com
- 3 months ago
Phreesia Named to G2's List of 2025 Best Healthcare Software Products
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to G2's 2025 Best Software Awards in the Best Healthcare Software Products category.
businesswire.com
- 3 months ago
8. Profile
Summary
Phreesia, Inc. PHR
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 1.56 B
Dividend Yield
0.00%
Description
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Contact
434 Fayetteville Street, Wilmington, NC, 27601
https://www.phreesia.com
IPO
Date
July 18, 2019
Employees
2082
Officers
Mr. David Linetsky
Senior Vice President of Network Solutions
Mr. Evan Roberts
Co-Founder & Chief Operating Officer
Ms. Allison C. Hoffman J.D.
General Counsel & Secretary
Ms. Yvonne Hui
Vice President & Principal Accounting Officer
Mr. Jack Callahan
Chief Technology Officer
Ms. Maureen McKinney
Vice President of Corporate Communications
Ms. Amy Beth VanDuyn
Senior Vice President of Human Resources
Ms. Melissa Mitchell
Chief Privacy Officer
Mr. Balaji Gandhi
Chief Financial Officer
Mr. Chaim Indig
Co-Founder, Chief Executive Officer & Director